Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 10:25 PM
NCT ID:
NCT02560558
Group ID:
EG001
Title:
Belatacept 4-weekly
Description:
Subjects who are stable on belatacept therapy at least one year after a renal transplant will receive belatacept infusion intravenously (IV) at 5 mg/kg every 4 weeks.
Belatacept: Belatacept is an immunosuppressive medication and will be given as an intravenous infusion at a dose of 5 mg/kg at 4-weekly or 8-weekly intervals.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
10
Serious Number At Risk:
82
Other Number Affected:
27
Other Number At Risk:
82
Study:
NCT02560558
Results Section:
NCT02560558
Adverse Events Module:
NCT02560558